Mental Map

From determining structures to figuring out functions, brain-mapping scientists are applying new technologies to understand the hub of the central nervous system.

Written byAbdul-Kareem Ahmed
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

PLOS, LIZA GROSSAs the dust settles around the launch of President Obama’s BRAIN Initiative, researchers are assessing the state of brain-mapping science. BRAIN aims to map the circuits of the human brain, linking electrical and chemical activity to behavior and cognition. Some believe mapping the brain and its activities would demystify the human mind and promote the development of new treatments. Others maintain that it is impractical to map the entire brain, with its seemingly infinite connections.

“It is seductive to compare this project to the Human Genome Project,” said Emery Brown, a neuroscientist and anesthesiologist at the Massachusetts Institute of Technology, and an advisor to the BRAIN Initiative. However, he added, “human brain mapping is far more complex.”

Comparatively speaking, neuroscientists are perhaps as close to mapping the entire brain today as Watson, Crick, and Franklin were to sequencing the entire human genome in the 1950s. Today’s neuroscientists are beginning to develop the technologies that will be required to achieve a much greater goal, which is likely to be fully realized only by future generations.

The brain can be observed at several different levels—from molecules to cells, to circuits and systems, and to the entire organ and its vast networks. Even ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies